Antigenics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Antigenics's estimated annual revenue is currently $5.4M per year.(i)
  • Antigenics's estimated revenue per employee is $155,000

Employee Data

  • Antigenics has 35 Employees.(i)
  • Antigenics grew their employee count by 3% last year.

Antigenics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Antigenics?

keywords:N/A

N/A

Total Funding

35

Number of Employees

$5.4M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Antigenics News

2022-04-20 - Therapeutic Vaccines Market Size, Scope And Forecast | Bavarian ...

Bavarian Nordic, Argos Therapeutics, Antigenics, Affiris, Celldex Therapeutics, Biovest International, Cel-Sci, Celtic Pharma,...

2022-04-17 - Agenus: Not Quite Enough

It went public in 2000 under the name Antigenics. Its S-1 described its initial therapeutic candidate Oncophage, at the time undergoing a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.6M35-42%N/A
#2
$6.8M35-10%N/A
#3
$5.7M35-17%N/A
#4
$6.9M350%N/A
#5
$3.5M35-8%N/A